RecruitingNCT05638503

Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension


Sponsor

Qilu Hospital of Shandong University

Enrollment

2,200 participants

Start Date

May 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators want to explore the relationship between different configurations of hypertension and the incidence of cardiovascular events by the guidelines reference range and EMINCA recommended reference range. Then the investigators want to enroll twenty research centers and 2200 hypertensions were planned to be collected and followed up in the 12th, 24th, 36th and 48th months after being enrolled in this study. Physical examination, ECG examination, laboratory examination, echocardiography and carotid ultrasound should be taken when baseline and follow-up. Echocardiographic measurement parameters were analyzed and the relationship between the echocardiographic measurement parameters and cardiovascular events and prognosis of hypertension.


Eligibility

Min Age: 30 YearsMax Age: 75 Years

Inclusion Criteria4

  • Age 30-75 years old;
  • No antihypertensive drugs were used and three blood pressure measurements were conducted on different days, with systolic blood pressure ≥ 140 mmHg (1 mmHg=0.133 kPa) and/or diastolic blood pressure ≥ 90 mmHg; or have a history of hypertension and are using antihypertensive drugs, even if the blood pressure is lower than 140/90 mmHg;
  • Left ventricular ejection fraction was normal (LVEF ≥ 0.5).
  • All patients agreed to participate in the experiment and signed the informed consent form.

Exclusion Criteria6

  • Secondary hypertension caused by renal parenchymal diseases, renal vascular diseases, coarctation of aorta and endocrine system diseases;
  • Severe cardiovascular and cerebrovascular diseases; heart valve disease; persistent atrial fibrillation and severe arrhythmia; previously undergone cardiovascular disease surgery;
  • Abnormal liver function; abnormal renal function and diabetes;
  • Pregnant or breastfeeding women;
  • Expected survival time due to non-cardiovascular disease\<4 years;
  • Patients with poor echocardiographic image quality.

Interventions

OTHERLeft ventricular hypertrophy

Hypertension with normal left ventricular geometry and left ventricular concentric remodeling

OTHERLeft ventricular non-hypertrophy

Hypertension with left ventricular concentric hypertrophy and left ventricular eccentric hypertrophy


Locations(1)

Qilu Hospital of Shandong University

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05638503


Related Trials